This clinical-stage precision medicine company develops a drug-discovery platform intended to apply computational techniques to protein motion.
Are there any plans on adding this stock on ISA accounts?
Hi @acamp it is not obvious to me why RLAY is not available in ISA accounts. On the face of it these are are normal shares, not depository receipts, traded on NASDAQ. Is this a minor clerical error or is there some some other reason?
1 Like
Let me look into this one. I can’t see an obvious reason for it to be excluded from the ISA account.
2 Likes
Updated this to make it ISA eligible.
2 Likes